406 related articles for article (PubMed ID: 17403698)
1. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
2. Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy.
Carvajal G; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Ruiz-Ortega M; Egido J; Mezzano S
Transplant Proc; 2008 Apr; 40(3):734-9. PubMed ID: 18455002
[TBL] [Abstract][Full Text] [Related]
3. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
[TBL] [Abstract][Full Text] [Related]
4. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
Lee H; O'Meara SJ; O'Brien C; Kane R
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
[TBL] [Abstract][Full Text] [Related]
5. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
6. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
[TBL] [Abstract][Full Text] [Related]
7. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
8. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
9. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
[TBL] [Abstract][Full Text] [Related]
10. [Effect of BMP-7 on the transdifferentiation of cultured human tubular epithelial cell induced by TGF-beta1].
Tan XY; Zheng FL; Yang JH; Duan L; Li Y; Zhou QG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):274-8. PubMed ID: 15266829
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-7 delays podocyte injury due to high glucose.
De Petris L; Hruska KA; Chiechio S; Liapis H
Nephrol Dial Transplant; 2007 Dec; 22(12):3442-50. PubMed ID: 17686813
[TBL] [Abstract][Full Text] [Related]
12. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats.
Ding G; Franki N; Kapasi AA; Reddy K; Gibbons N; Singhal PC
Exp Mol Pathol; 2001 Feb; 70(1):43-53. PubMed ID: 11170790
[TBL] [Abstract][Full Text] [Related]
13. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
BMC Nephrol; 2005 Dec; 6():16. PubMed ID: 16367998
[TBL] [Abstract][Full Text] [Related]
14. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.
Dolan V; Murphy M; Sadlier D; Lappin D; Doran P; Godson C; Martin F; O'Meara Y; Schmid H; Henger A; Kretzler M; Droguett A; Mezzano S; Brady HR
Am J Kidney Dis; 2005 Jun; 45(6):1034-9. PubMed ID: 15957132
[TBL] [Abstract][Full Text] [Related]
15. In situ expression of connective tissue growth factor in human crescentic glomerulonephritis.
Kanemoto K; Usui J; Nitta K; Horita S; Harada A; Koyama A; Aten J; Nagata M
Virchows Arch; 2004 Mar; 444(3):257-63. PubMed ID: 14758550
[TBL] [Abstract][Full Text] [Related]
16. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells.
Rodrigues-Diez R; Lavoz C; Carvajal G; Rayego-Mateos S; Rodrigues Diez RR; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
Nephron Exp Nephrol; 2012; 122(1-2):62-74. PubMed ID: 23548835
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
18. Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis.
Kanemoto K; Usui J; Tomari S; Yokoi H; Mukoyama M; Aten J; Weening JJ; Nagata M
Lab Invest; 2003 Nov; 83(11):1615-25. PubMed ID: 14615415
[TBL] [Abstract][Full Text] [Related]
20. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
